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Abstract
Background: Conservative management of Warthin tumor (WT) may be a viable alternative to surgery, but there
are concerns of missed malignancies on fine needle aspiration biopsy (FNAB). The purpose of this study is to
measure the sensitivity and positive predictive value of FNAB for WT, and to identify clinical features associated with
WT that can aid in this diagnosis.
Methods: Retrospective analysis of patients from January 1, 2006 to April 30, 2017 at a tertiary care center in
London, Ontario, Canada. All patients with a diagnosis of WT on FNAB or resection were included. Electronic
medical records were identified for 177 patients that fit the criteria. Study outcomes included the sensitivity and
positive predictive value of FNAB alone for WT, and, when including clinical features associated with WT.
Results: The mean age of patients in this study was 63.2 years (SD 10.4); 115 (65%) were male, and 157 (89%) were
past or present smokers. The measured sensitivity and positive predictive value of FNAB for WT were 95.8 and
97.2% respectively. Two cases were classified as WT on FNAB but confirmed at resection as mucoepidermoid
carcinoma and acinic cell carcinoma. When only patients with multifocal, bilateral or incidental tumors were
assessed, sensitivities and positive predictive values for each were 100%. Isolating for inferior pole location also
resulted in a positive predictive value of 100%.
Conclusions: The sensitivity and positive predictive value of FNAB for WT in this study are high, with two false
negatives on FNAB. Multifocal, bilateral, incidentaloma and inferior pole location were identified as potential clinical
features that may increase the diagnostic confidence for WT, strengthening the argument for conservative
management in these patients. Overall, this study serves as an initial exploration into whether clinical features may
be included with FNAB results to improve the sensitivity and positive predictive value of diagnosing WT. Further
research is necessary before these findings can be translated into clinical practice.
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Background
Warthin tumor (WT), the second most common benign
tumor of the parotid gland, makes up approximately
15% of all parotid tumors [1]. The treatment of choice is
superficial parotidectomy [2, 3], but this may be associ-
ated with complications including both temporary and
permanent facial nerve injury, Frey’s syndrome, and
hematoma [4, 5]. WT has a slow growth rate, is typically
asymptomatic, is more common in smokers, is rarely as-
sociated with malignancy, and generally occurs in pa-
tients in their 60s [2, 6]. In recent years, more patients
are diagnosed with WT as an incidental finding on PET
scan. Given that many of these patients are older, usually
smokers with other comorbidities and the tumor is
found incidentally, conservative management is an at-
tractive alternative to surgery [3, 4, 7]. Literature on the
safety of observation for patients with WT is sparse [3].
In addition to the paucity of research in this area, con-
servative management has not been widely adopted due
to the uncertainty of the pre-operative diagnosis in the
form of fine needle aspiration biopsy (FNAB) [3, 4, 7].
FNAB is minimally invasive and cost-effective [4], but suf-
fers from low sensitivity, specificity and accuracy [7, 8].
This is compounded by the problem that the FNAB
appearance of WT may sometimes overlap with other tu-
mors, some of which are malignant [8]. Thus, confirming
the diagnosis with resection is important because of these
possible missed malignancies.
Several clinical features have been associated with
WT, namely advanced age, smoking, and the male sex
[4, 7, 9, 10]. WT is also frequently seen as multifocal, bi-
lateral, and located in the inferior pole of the parotid [9].
In addition, it is not uncommon for WT to be discov-
ered as an incidentaloma on imaging [11–13]. Although
many papers have reported these associations, there has
not been a study to our knowledge that has examined if
these features could aid in the diagnosis of WT.
In the present investigation, we analyzed the pathology
data of patients with parotid tumors who have received
both FNAB and resection confirmation of the diagnosis
to determine the sensitivity and positive predictive value
(PPV) of FNAB for WT. We then included the clinical
features of these patients into our analysis to determine
if any of the features associated with WT improve the
sensitivity and positive predictive value of the diagnosis.
Methods
A retrospective analysis was conducted on all patients
with a diagnosis of WT on FNAB or resection present-
ing to the London Health Sciences Centre (LHSC)
Department of Otolaryngology-Head and Neck Surgery
from January 1, 2006 to April 30, 2017. Patients who
met these criteria were identified through a search of the
electronic pathology database. The electronic medical
records of these patients were accessed, which contain
all information relating to imaging, pathology, proce-
dures and clinic reports. Data from these records were
collected, including the FNAB diagnosis, resection diag-
nosis, age, gender, smoking history, symptoms, location
of the tumor in the parotid, and if the tumor was multi-
focal, bilateral or an incidentaloma.
Besides the resection diagnosis, only information
known at presentation to clinic or on initial workup was
collected, in keeping with the goal of this study. Age was
defined as the age at presentation and patients were classi-
fied as smokers if they had any history of smoking. Only
symptoms noted at initial presentation were recorded, any
symptoms that developed later were not. Similarly, the
tumor was recorded as multifocal or bilateral only if
discovered on initial imaging workup. Patients with a diag-
nosis of WT or a history of parotidectomy on the contra-
lateral side prior to January 1, 2006 were also considered
bilateral. The inferior pole of the parotid was defined as
synonymous with ‘parotid tail’, ‘angle of the mandible’ and
‘lower parotid’. The tumor was considered an incidenta-
loma if the tumor was discovered on any imaging modality
including PET, CT, MRI and ultrasound performed for an
unrelated medical condition or symptom.
The FNAB diagnoses were classified as neoplasm
consistent with Warthin tumor (WT), negative for ma-
lignancy (not WT), or indeterminate. Phrases such as ‘fa-
vours Warthin,’ ‘suggestive of Warthin,’ ‘consistent with
Warthin,’ and ‘suspicious for Warthin’ were considered
a diagnosis of WT. An indeterminate diagnosis was con-
sidered to include phrases such as ‘oncocytic neoplasm,’
‘differential includes Warthin,’ ‘cystic contents,’ and ‘in-
sufficient material for diagnosis.’ Diagnoses classified as
negative for malignancy (not WT) also used the phrases
‘favours,’ ‘suggestive of,’ consistent with’ and ‘suspicious
for,’ but identified a tumor other than WT.
There was no clinical record of smoking status for 12
(6.8%) patients and 14 (7.9%) patients had no record of
whether the tumor was located in the inferior pole.
These patients were assumed to be negative with
relation to the clinical feature being studied, to prevent
inflation of our results. For example, they were assumed
to be non-smokers or the tumor was assumed to be in
the body of the parotid.
The collected data was used to calculate the sensitivity
and PPV of FNAB for WT at our institution. Sensitivity
was defined as the number of patients with both FNAB
and resection diagnoses of WT, over the number of pa-
tients with a resection diagnosis of WT and a FNAB
diagnosis of either WT or not WT. Similarly, PPV was
defined as the number of patients with both FNAB and
resection diagnoses of WT, over the number of patients
with a FNAB diagnosis of WT and a resection diagnosis
of either WT or not WT. This study was approved by
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Western University’s Health Sciences Research Ethics
Board and Lawson Health Research Institute.
Results
Electronic medical records were present for 177 patients
with a diagnosis of WT on FNAB or resection from
January 1, 2006 to April 30, 2017 at LHSC. The mean
age of these patients was 63.2 years (SD 10.4); 115 (65%)
of them were male, and 157 (89%) had smoked some-
time in their life. Of the 177 cases reviewed, 127 (72%)
of the patients presented asymptomatically, 145 (82%) of
the tumors were in the inferior pole of the parotid, and
28 (16%) were incidentalomas found on imaging. On ini-
tial workup, 36 (20%) of the cases were found to be
multifocal, and 36 (20%) were bilateral. The patients
were then subdivided based on their FNAB and resec-
tion diagnoses, and their clinical characteristics (Table 1).
One-hundred and twenty-five patients had histopatho-
logical diagnoses of WT; the corresponding FNAB diag-
noses were as follows: 69 (55.2%) were diagnosed with
WT, 3 (2.4%) were diagnosed with not WT, 28 (22.4%)
were indeterminate, and 25 (20%) had no record of
diagnosis on FNAB.
Using the subgroups created, the sensitivity and PPV
of FNAB for WT at our institution were calculated.
There were 69 patients with WT diagnoses on both
FNAB and resection, and 3 patients with a FNAB
favouring not WT but a resection identifying WT,
resulting in a sensitivity of 95.8%. Of the 3 patients with
FNAB not classified as WT, the FNAB diagnoses were:
chronic sialadenitis, squamoid neoplasm, and mucinous
cystic lesion. There were also 2 patients with a FNAB
diagnosis of WT but a resection without WT, leading to
a PPV of 97.2%. In these cases, the tumors were classi-
fied as mucoepidermoid carcinoma and acinic cell car-
cinoma in the resection specimen.
To identify clinical features of interest, the sensitivity
and PPV of FNAB for WT after isolating for the various
features were calculated (Table 2). Of note, sensitivity
and PPV were found to be 100% when using FNAB to
diagnose WT for tumors that were multifocal, bilateral
or found as an incidentaloma. PPV was also 100% for
tumors that were diagnosed as WT on FNAB that were
located in the inferior pole of the parotid.
Discussion
The data demonstrates that several of the clinical
features associated with WT investigated in this study
(multifocal, bilateral, incidentaloma and inferior pole lo-
cation) can improve our confidence in a FNAB diagnosis
favoring WT. In this study, when the FNAB was consist-
ent with WT, WT was identified on final histology in all
patients when the tumor was multifocal, bilateral or
found as an incidentaloma. Also, when the tumor had
any one of these three features or was in the inferior
pole of the parotid, then all patients in this study with a
FNAB diagnosis favoring WT were found to have WT at
resection.
Comparing the overall sensitivity and PPV of FNAB
for WT at our institution with values in the literature
(Table 3), it appears that LHSC outcomes are compar-
able or better than other institutions [4, 7, 8, 10, 14].
This may be related to cytopathology specialization at
LHSC, the increased experience with WT and pitfalls in
diagnoses of salivary gland tumours on FNAB, and the
strict criteria used for WT diagnosis on FNAB. Despite
the high PPV found however, two tumors initially classi-
fied as WT in our study were malignant at resection,
highlighting one of the reasons why many surgeons still
recommend performing a parotidectomy. Other studies
have also found that the majority of the cases misdiag-
nosed as WT turn out to be malignant [4], which may
be why most research to date on the management of
WT only examine various extents of surgery without
including conservative management [15, 16]. Acinic cell
carcinoma and mucoepidermoid carcinoma are well-
known pitfalls in the diagnosis of WT on FNAB [17–19].
To the best of our knowledge, this is the first study to
examine the inclusion of clinical features with the FNAB
diagnosis of WT to determine the possibility of conser-
vative management. An increasing number of these
tumors are being diagnosed [2, 20], and this increase is



















Warthin Warthin 69 62.0 (9.6) 50 (72) 65 (94) 48 (70) 56 (81) 18 (26) 18 (26) 10 (14)
Warthin No record 50 68.1 (10.9) 29 (58) 43 (86) 39 (78) 41 (82) 6 (12) 9 (18) 15 (30)
Warthin Not Warthin 2 54.5 (9.2) 1 (50) 1 (50) 1 (50) 0 (0) 0 (0) 0 (0) 0 (0)
Not Warthin Warthin 3 55.0 (14.1) 2 (67) 3 (100) 3 (100) 2 (67) 0 (0) 0 (0) 0 (0)
Indeterminate Warthin 28 61.5 (9.8) 15 (54) 24 (86) 18 (64) 24 (86) 6 (21) 4 (14) 2 (7)
No record Warthin 25 60.2 (9.2) 18 (72) 21 (84) 18 (72) 22 (88) 6 (24) 5 (20) 1 (4)
aMeasured at presentation
bAny history of smoking was included
cTumor characteristic on initial workup
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potentially linked to the increased use of imaging in
health care. In our study, 28 (16%) of patients were un-
aware that they had a parotid tumor until it was inciden-
tally noted on imaging done for an unrelated medical
condition. Given that WT is often asymptomatic, visu-
ally unnoticeable, slow growing and rarely associated
with malignancy [2, 6], conservatively managing the WT
is an attractive alternative to surgery. In our study, 50
(41%) of patients with a FNAB diagnosis of WT had no
record of resection. This may be due to the patient
choosing conservative management, not being fit for
surgery, or undergoing surgery at another center. This
proportion seems slightly higher at other institutions.
Vlantis et al. reported that 36 (47%) of their 76 WT
cases were treated conservatively [7]. Veder et al. re-
ported that conservative treatment was done for 177
(57%) of their 310 WT cases [4]. In spite of our findings
indicating that there is a high sensitivity and PPV of WT
in patients with clinical features suggestive of WT and
an FNAB indicating WT, we hesitate to recommend
observation given our small sample size. However, we
acknowledge that some clinicians will opt for observa-
tion in medically unfit patients following careful discus-
sion with the patient. The long-term outcomes of this
group of patients with WT who undergo observation
requires further investigation.
Strengths of our study include the overall
generalizability of the results, as our patient characteris-
tics are in concordance with the literature [4, 7, 9, 10].
We limited our sample to FNAB and final histology
from a tertiary care centre with pathologists experienced
in salivary gland cytology and histology, limiting the
heterogeneity of pathologic findings. This study also ex-
amined the vast majority of clinical features associated
with WT highlighted in the literature [4, 7, 9–13]. The
ease of access to imaging at our tertiary care centre
allowed us to more accurately label tumors as multifocal,
bilateral or in the inferior pole of the parotid. Further-
more, the concrete definitions used for the clinical fea-
tures in the methodology allows for better comparisons
to be made with past and future studies.
One of the limitations of this study is that the patients
managed conservatively could not be included in the
sensitivity and PPV calculations. There are numerous
reasons as to why a patient might not have undergone
surgery, one of which could be the benign clinical pres-
entation of the lesion. This would suggest that the sensi-
tivity and PPV measured in this study would not be
adversely affected if resection results were obtained for
all patients. Another limitation is that the heterogeneous
categorization of FNAB diagnoses were not fully cap-
tured. Phrases expressing various degrees of certainty
with regards to the FNAB diagnosis of WT were
grouped together without risk stratification. There were
also a large number of patients (n = 56) who did not
have a FNAB available (n = 25) or were classified as ‘Not
Warthin’ (n = 3) or ‘Indeterminate’ (n = 28). Many of
these patients may have been clinically suspicious for
WT. Indeterminate FNABs were either cystic contents,
insufficient or demonstrated atypia or features suggestive
of another salivary gland neoplasm. Repeating the FNAB
and reviewing the FNAB records for those that were
classified as ‘no record’ may have strengthened our
findings. A further limitation of this study is the small
sample size, preventing us from drawing significant
conclusions from our results. However, this study has
been successful in identifying specific clinical features
that may be of use in the diagnosis of WT, warranting
further research across multiple institutions or spanning
a longer time frame.
Conclusions
The sensitivity and PPV of FNAB consistent with WT
diagnosing a final histology of WT measured in this
study are high, with two false negatives. Multifocal,
bilateral, incidentaloma and inferior pole location were
identified as potential clinical features that may increase
the diagnostic confidence for WT, strengthening the ar-
gument for conservative management in these patients.
Overall, this study serves as an initial exploration into
Table 3 Comparison of sensitivity and PPV of FNAB for WT
among the literature
Study Sensitivity (%) PPV (%)
Current study (n = 74) 95.8 97.2
Parwani and Ali (n = 27)14 74 –
Kim et al. (n = 21)10 85.7 –
Jeong et al. (n = 35)8 76.5 96.3
Veder et al. (n = 133)4 – 95.5
Vlantis et al. (n = 40)7 – 95
Table 2 Sensitivity and PPV of FNAB for WT after isolating for
various clinical features
Clinical feature Sensitivity (%) PPV (%)
Age 60+ (n = 42)a 97.6 97.6
Male (n = 53) 96.2 98.0
Smoker (n = 69)b 95.6 98.5
Asymptomatic (n = 52)a 94.1 98.0
Inferior pole (n = 58) 96.6 100
Multifocal (n = 18)c 100 100
Bilateral (n = 18)c 100 100
Incidentaloma (n = 10) 100 100
aMeasured at presentation
bAny history of smoking was included
cTumor characteristic on initial workup
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whether patient clinical features may be included with
FNAB diagnosis to improve the sensitivity and PPV of a
WT diagnosis. Future research projects should examine
whether further subclassification of an indeterminate
FNAB or repeat FNAB is helpful to improve sensitivity
and PPV. A larger sample size is required in order to
make definitive recommendations about observation of
patients with FNAB and clinical features suggestive of
WT.
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